thalidomide bms 50 mg hard capsules
neopharm ltd - thalidomide - hard capsule - thalidomide 50 mg - thalidomide - multiple myeloma : * for the treatment of multiple myeloma after failure of standard therapies. * thalidomide bms 50 mg hard capsules in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma. * thalidomide bms in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma > or = 65 years or ineligible for high dose chemotherapy. erythema nodosum leprosum: for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl). thalidomide is not indicated as monotherapy for such enl treatment in the presence of moderate to severe neuritis. it is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence.
thalidomide celgene 50 mg hard capsules
neopharm ltd - thalidomide - hard capsule - thalidomide 50 mg - thalidomide - multiple myeloma : 1. for the treatment of multiple myeloma after failure of standars therapies. 2. thalidomide celgene 50 mg hard capsules in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma. 3. thalidomide celgene in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma > or = 65 years or ineligible for high dose chemotherapy. erythema nodosum leprosum: 4. for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl). thalidomide is not indicated as monotherapy for such enl treatment in the presence of moderate to severe neuritis. it is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence.בקשה לעדכון משטר מינון 4/2/2020
enerzair breezhaler 114 mcg46 mcg136 mcg
novartis israel ltd - glycopyrronium as bromide; indacaterol as acetate; mometasone furoate - hard capsule - mometasone furoate 160 mcg; glycopyrronium as bromide 50 mcg; indacaterol as acetate 150 mcg - mometasone - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.important limitations of use:enerzair breezhaler is not indicated in patients with copd.
spiriva
boehringer ingelheim israel ltd. - tiotropium bromide - inhalation powder hard capsules - tiotropium bromide 18 mcg - tiotropium bromide - tiotropium bromide - tiotropium is a bronchodilator for the maintenance treatment of chronic obstructive pulmonary disease (copd).
foradil capsule for inhalation 12 mcgcapsule
novartis (singapore) pte ltd - formoterol fumarate - powder, metered - 12 mcg/capsule - formoterol fumarate 12 mcg/capsule
favynd 18 microgram inhalation powder, capsule
boehringer ingelheim international gmbh - tiotropium bromide monohydrate - inhalation powder, capsule - 18 microgram - anticholinergics
onbrez breezhaler powder for inhalation, hard capsules
novartis farmaceutica s.a. - indacaterol (indacaterol maleate) - powder for inhalation, hard capsules - 150mcg
onbrez breezhaler powder for inhalation, hard capsules
novartis farmaceutica s.a. - indacaterol (indacaterol maleate) - powder for inhalation, hard capsules - 300mcg
atectura breezhaler inhalation powder, capsules hard
siegfried barbera s.l. - indacaterol (indacaterol acetate), mometasone fuorat - inhalation powder, capsules hard - 150mcg+ 320mcg
nibix 100 mg hard capsule
aspen healthcare malta limited 89, level 0 triq is-siggiewi siggiewi, sgw 2021, , malta - imatinib mesilate - hard capsule - imatinib mesilate 100 mg - antineoplastic agents